In last trading session, Virios Therapeutics Inc (NASDAQ:VIRI) saw 0.42 million shares changing hands with its beta currently measuring 1.59. Company’s recent per share price level of $0.18 trading at $0.0 or -3.58% at ring of the bell on the day assigns it a market valuation of $4.94M. That closing price of VIRI’s stock is at a discount of -511.11% from its 52-week high price of $1.10 and is indicating a premium of 11.11% from its 52-week low price of $0.16. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.23 million shares which gives us an average trading volume of 1.21 million if we extend that period to 3-months.
Virios Therapeutics Inc (NASDAQ:VIRI) trade information
Upright in the red during last session for losing -3.58%, in the last five days VIRI remained trading in the red while hitting it’s week-highest on Tuesday, 09/03/24 when the stock touched $0.18 price level, adding 9.95% to its value on the day. Virios Therapeutics Inc’s shares saw a change of -69.04% in year-to-date performance and have moved -1.11% in past 5-day. Virios Therapeutics Inc (NASDAQ:VIRI) showed a performance of -4.97% in past 30-days. Number of shares sold short was 0.33 million shares which calculate 0.25 days to cover the short interests.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Virios Therapeutics Inc (VIRI) estimates and forecasts
Statistics highlight that Virios Therapeutics Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -53.16% of value to its shares in past 6 months, showing an annual growth rate of 21.43% while that of industry is 17.90. Apart from that, the company came raising its revenue forecast for fiscal year 2024.
2.0 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of nan for the same. And 2.0 analysts are in estimates of company making revenue of nan in the next quarter. Company posted nan and nan of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -2.02% during past 5 years.
Virios Therapeutics Inc (NASDAQ:VIRI)’s Major holders
Insiders are in possession of 6.74% of company’s total shares while institution are holding 6.12 percent of that, with stock having share float percentage of 6.56%. Investors also watch the number of corporate investors in a company very closely, which is 6.12% institutions for Virios Therapeutics Inc that are currently holding shares of the company. VANGUARD GROUP INC is the top institutional holder at VIRI for having 0.21 million shares of worth $44910.0. And as of 2024-06-30, it was holding 1.0847 of the company’s outstanding shares.
The second largest institutional holder is GEODE CAPITAL MANAGEMENT, LLC, which was holding about 0.17 million shares on 2024-06-30. The number of shares represents firm’s hold over 0.906 of outstanding shares, having a total worth of $37516.0.
